Abstract
Background
Predicting the prognosis of patients with adrenocortical carcinoma (ACC) is difficult, due to its unpredictable behavior. The aim of this study is to develop and validate a nomogram to predict survival outcomes in patients with ACC.
Methods
Nomograms were established using the data collected from the Surveillance, Epidemiology, and End Results (SEER) database. Based on univariate and multivariate Cox regression analyses, we identified independent risk factors for overall survival (OS) and cancer-specific survival (CSS). Concordance indexes (c-indexes), the area under the receiver operating characteristics curve (AUC) and calibration curve were used to evaluate predictive performance of these models. The clinical use of nomogram was measured by decision curve analysis (DCA) and clinical impact curves.
Results
A total of 855 eligible patients, randomly divided into training (n = 600) and validation cohorts (n = 255), were included in this study. Based on the independent predictors, the nomograms were established and demonstrated good discriminative abilities, with C-indexes for OS and CSS were 0.762 and 0.765 in training cohorts and 0.738 and 0.758 in validation cohorts, respectively. The AUC and calibration plots also demonstrated a good performance for both nomograms. DCA indicated that the two nomograms provide clinical net benefits.
Conclusion
We unveiled the prognostic factors of ACC and developed novel nomograms that predict OS and CSS more accurately and comprehensively, which can help clinicians improve individual treatment, making proper clinical decisions and adjusting follow-up management strategies.
Similar content being viewed by others
References
Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg 30(5):872–878. https://doi.org/10.1007/s00268-005-0329-x
Fassnacht M, Kroiss M, Allolio B (2013) Update in adrenocortical carcinoma. J Clin Endocrinol Metab 98(12):4551–4564. https://doi.org/10.1210/jc.2013-3020
Icard P, Goudet P, Charpenay C et al (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 25(7):891–897. https://doi.org/10.1007/s00268-001-0047-y
Ayala-Ramirez M, Jasim S, Feng L et al (2013) Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol 169(6):891–899. https://doi.org/10.1530/EJE-13-0519
Sharma E, Dahal S, Sharma P et al (2018) The characteristics and trends in adrenocortical carcinoma: a United States Population Based Study. J Clin Med Res 10(8):636–640. https://doi.org/10.14740/jocmr3503w
Allolio B, Hahner S, Weismann D, Fassnacht M (2004) Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60(3):273–287. https://doi.org/10.1046/j.1365-2265.2003.01881.x
Zini L, Capitanio U, Jeldres C et al (2009) External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma. BJU Int 104(11):1661–1667. https://doi.org/10.1111/j.1464-410X.2009.08660.x
Li Y, Bian X, Ouyang J, Wei S, He M, Luo Z (2018) Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma. Cancer Manag Res 10:6949–6959. https://doi.org/10.2147/CMAR.S187169
Cronin KA, Ries LAG, Edwards BK (2014) Preface. Cancer 120(S23):3755–3757. https://doi.org/10.1002/cncr.29049
Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259. https://doi.org/10.1158/1078-0432.CCR-04-0713
DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Pathology and genetics of tumours of endocrine organs. IARC, Lyon
Moons KG, Altman DG, Reitsma JB et al (2015) Transparent reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1–W73. https://doi.org/10.7326/M14-0698
Sauerbrei W, Boulesteix AL, Binder H (2011) Stability investigations of multivariable regression models derived from low- and high-dimensional data. J Biopharm Stat 21(6):1206–1231. https://doi.org/10.1080/10543406.2011.629890
Royston P, Altman DG (2013) External validation of a Cox prognostic model: Principles and methods. BMC Med Res Methodol. https://doi.org/10.1186/1471-2288-13-33
Vickers AJ, Cronin AM, Elkin EB, Gonen M (2008) Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak 8:1–17. https://doi.org/10.1186/1472-6947-8-53
Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26(6):565–574. https://doi.org/10.1177/0272989X06295361
Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34(18):2157–2164. https://doi.org/10.1200/JCO.2015.65.9128
Bilimoria KY, Shen WT, Elaraj D et al (2008) Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113(11):3130–3136. https://doi.org/10.1002/cncr.23886
Stojadinovic A, Ghossein RA, Hoos A et al (2002) Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 20(4):941–950. https://doi.org/10.1200/JCO.2002.20.4.941
Harrison LE, Gaudin PB, Brennan MF (1999) Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 134(2):181–185. https://doi.org/10.1001/archsurg.134.2.181
Şişman P, Şahin AB, Peynirci H et al (2017) Adrenokortikal karsinom: Tek merkez deneyimi. Turkish J Urol 43(4):462–469. https://doi.org/10.5152/tud.2017.81598
Wang S, Chen S-S, Gao W-C et al (2017) Prognostic factors of adrenocortical carcinoma: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Asian Pac J Cancer Prev 18(10):2817–2823. https://doi.org/10.22034/APJCP.2017.18.10.2817
Paton BL, Novitsky YW, Zerey M et al (2006) Outcomes of adrenal cortical carcinoma in the United States. Surgery 140(6):914–920. https://doi.org/10.1016/j.surg.2006.07.035
Vaidya A, Nehs M, Kilbridge K (2019) Treatment of adrenocortical carcinoma. Surg Pathol Clin 12(4):997–1006. https://doi.org/10.1016/j.path.2019.08.010
Sabolch A, Feng M, Griffith K, Hammer G, Doherty G, Ben-Josef E (2011) Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys 80(5):1477–1484. https://doi.org/10.1016/j.ijrobp.2010.04.030
Fassnacht M, Hahner S, Polat B et al (2006) Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 91(11):4501–4504. https://doi.org/10.1210/jc.2006-1007
Hescot S, Slama A, Lombes A et al (2013) Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells. Endocr Relat Cancer 20(3):371–381. https://doi.org/10.1530/ERC-12-0368
Fitzgerald M, Saville BR, Lewis RJ (2015) Decision curve analysis. JAMA 313(4):409–410. https://doi.org/10.1001/jama.2015.37
Kerr KF, Brown MD, Zhu K, Janes H (2016) Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol 34(21):2534–2540. https://doi.org/10.1200/JCO.2015.65.5654
Fassnacht M, Johanssen S, Quinkler M et al (2009) Limited prognostic value of the 2004 international union against cancer staging classification for adrenocortical carcinoma. Cancer 115(2):243–250. https://doi.org/10.1002/cncr.24030
Gaujoux S, Grabar S, Fassnacht M et al (2011) Β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma. Clin Cancer Res 17(2):328–336. https://doi.org/10.1158/1078-0432.CCR-10-2006
Acknowledgements
We thank the seer database and the data gatherers in every registries.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists in this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, H., Naji, Y., Yan, M. et al. Development and validation of prognostic nomograms in patients with adrenocortical carcinoma: a population-based study. Int Urol Nephrol 52, 1057–1071 (2020). https://doi.org/10.1007/s11255-020-02413-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02413-1